Studies to better define the inhibitory functions and the clinical relevance of HLA-E in CLL have revealed the presence of soluble HLA-E (sHLA-E) in the plasma of CLL patients [175]. The gene discussed is HLA-E; the disease is B-cell chronic lymphocytic leukemia.